Credit: A. Ponce-Salvatierra / Max-Planck-Institut für biophysikalische Chemie
DNA does not always adopt the form of the
double helix which is associated with the genetic code; it can also form
intricate folds and act as an enzyme: a deoxyribozyme. A researcher
from Spain and other scientists from the Max Planck Institute for
Biophysical Chemistry (Germany) have solved the first three-dimensional
structure of this biomolecule that has proved much more flexible than
previously thought.
Chemists successfully isolated deoxyribozymes over 20 years ago -- a
DNA with the ability to act as an enzyme. However, until now they had
not been able to associate its catalytic activity with the
three-dimensional structure that provides such function to this DNA.
Now, European scientists from the Max Planck Institute for
Biophysical Chemistry in Göttingen (Germany) have succeeded after having
bombarded this molecule with X-rays in the SLS synchrotron in
Switzerland. The results, published in the journal 'Nature', have made
it possible to build the crystal structure of this 'DNAzyme' using
computers.
"We have uncovered the first structure of a deoxyribozyme, and for
the first time we can see that this DNA is capable of taking on forms as
complex as those of protein enzymes or ribozymes ‑an RNA capable of
catalytic activity," points out the Spanish scientist Almudena
Ponce-Salvatierra, a member of the European group responsible for
accomplishing this breakthrough.
The researchers have broken the paradigm of the supposed stiffness of
DNA -a sort of symbol that is popularly associated with the double
helix of Watson and Crick-, by demonstrating that this molecule can also
adopt complicated three-dimensional structures in addition to being
much more flexible than what was previously thought.
Deoxyribozymes are single strands of DNA that are synthesised in the
laboratory in order to exploit their catalytic activity. Specifically,
the researchers have successfully visualised the structure of a
deoxyribozyme named 9DB1, which catalyses the ligation of two RNA
strands.
According to the authors of this study, the findings help us to
better understand the molecular principles of the reactions in which
this type of molecule plays a part.
"There are many applications for deoxyribozymes, from catalysing the
ligation of two DNA or RNA fragments, to repairing any of its
components, such as thymine," explains Ponce-Salvatierra, who announced
that the clinical trials for its use in medicine are already underway.
Journal Reference:
- Almudena Ponce-Salvatierra, Katarzyna Wawrzyniak-Turek, Ulrich Steuerwald, Claudia Höbartner, Vladimir Pena. Crystal structure of a DNA catalyst. Nature, 2016; 529 (7585): 231 DOI: 10.1038/nature16471
Courtesy: ScienceDaily
No comments:
Post a Comment